Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion.
Oncotarget
; 7(32): 51626-51639, 2016 08 09.
Article
in En
| MEDLINE
| ID: mdl-27438149
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urinary Bladder Neoplasms
/
Drug Screening Assays, Antitumor
/
Carcinoma, Transitional Cell
/
PTEN Phosphohydrolase
/
ErbB Receptors
/
Dasatinib
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Oncotarget
Year:
2016
Document type:
Article
Country of publication: